No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Aryl Hydrocarbon Hydroxylases / genetics
-
Aryl Hydrocarbon Hydroxylases / metabolism
-
Body Mass Index
-
Clopidogrel
-
Coronary Artery Disease / blood
-
Coronary Artery Disease / drug therapy*
-
Cytochrome P-450 CYP2C19
-
Genotype
-
Humans
-
Phenotype
-
Platelet Aggregation / drug effects*
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Platelet Aggregation Inhibitors / adverse effects
-
Platelet Aggregation Inhibitors / pharmacokinetics
-
Platelet Function Tests
-
Polymorphism, Genetic
-
Predictive Value of Tests
-
Receptors, Purinergic P2Y12 / blood
-
Receptors, Purinergic P2Y12 / drug effects
-
Risk Assessment
-
Risk Factors
-
Ticlopidine / administration & dosage
-
Ticlopidine / adverse effects
-
Ticlopidine / analogs & derivatives*
-
Ticlopidine / pharmacokinetics
Substances
-
P2RY12 protein, human
-
Platelet Aggregation Inhibitors
-
Receptors, Purinergic P2Y12
-
Clopidogrel
-
Aryl Hydrocarbon Hydroxylases
-
CYP2C19 protein, human
-
Cytochrome P-450 CYP2C19
-
Ticlopidine